Impact of HIV and Its Treatment on Reverse Cholesterol Transport
NCT00168233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2012-01-20
Summary
To investigate the effect of treatment of HIV infection with highly active antiretroviral therapy on individual steps of reverse cholesterol transport, endothelial function and intima-media thickness in HIV patients.
Conditions
- HIV Infections
Sponsors & Collaborators
-
National Health and Medical Research Council, Australia
collaborator OTHER -
The Alfred
lead OTHER
Principal Investigators
-
Dmitri Sviridov, Dr · Baker Heart Research Institute, Commercial Road, Melbourne
-
Jennifer Hoy, A/Prof · Alfred Hospital, Melbourne, Vic 3004
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-30
- Primary Completion
- 2010-09-30
- Completion
- 2011-03-31
Countries
- Australia
Study Locations
More Related Trials
-
Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months
NCT01436136 ·Status: COMPLETED ·Phase: NA
-
Understanding the Increased Risk of Cardiovascular Disease in People With HIV
NCT00577681 ·Status: COMPLETED
-
Utilizing Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Patients on Long-Term Antiretroviral Therapy
NCT02191306 ·Status: COMPLETED
-
Measurement for Viral Reservoir and Immune Function in HIV-1-infected Patients Under Antiretroviral Therapy
NCT04068441 ·Status: COMPLETED
-
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
NCT01519141 ·Status: COMPLETED
-
Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
NCT00000883 ·Status: COMPLETED ·Phase: NA
-
Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs
NCT00050908 ·Status: COMPLETED
-
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
NCT01089114 ·Status: COMPLETED
-
Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
NCT00575939 ·Status: COMPLETED
-
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
NCT01667068 ·Status: COMPLETED
-
Statin Therapy to Improve Atherosclerosis in HIV Patients
NCT00965185 ·Status: COMPLETED ·Phase: NA
-
Carotid Artery Thickness in HIV Infected and Uninfected Adults
NCT00007319 ·Status: COMPLETED
-
Predictors of Drug Hypersensitivity in HIV Infected Subjects
NCT00168220 ·Status: WITHDRAWN
-
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
NCT02624180 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
NCT01119729 ·Status: COMPLETED
-
Endothelial Dysfunction as a Risk Factor in HIV Study
NCT00039663 ·Status: COMPLETED ·Phase: PHASE1
-
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
NCT01196273 ·Status: COMPLETED
-
HIV Infection And Evolvement of Atherosclerotic Plaque
NCT04810364 ·Status: UNKNOWN
-
HIV-Associated Heart Disease
NCT00005229 ·Status: COMPLETED
-
HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)
NCT00043641 ·Status: COMPLETED
-
Identification and Quantification of HIV CNS Latency Biomarkers
NCT02989285 ·Status: UNKNOWN
-
The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients
NCT00006442 ·Status: COMPLETED
-
Long-term Follow-up of HIV Infected Patients Identified During Early Infection
NCT00086372 ·Status: COMPLETED
-
Examining the Link Between Heart Disease and HIV Infection in Women
NCT00312468 ·Status: COMPLETED
-
Analysis of HIV-1 Replication During Antiretroviral Therapy
NCT00767312 ·Status: ENROLLING_BY_INVITATION